Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Receivables - Other: 2022-2024

Historic Receivables - Other for Amylyx Pharmaceuticals (AMLX) over the last 3 years, with Dec 2024 value amounting to $100,000.

  • Amylyx Pharmaceuticals' Receivables - Other changed negligibly% to $100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $100,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $100,000 for FY2024, which is 80.00% down from last year.
  • According to the latest figures from FY2024, Amylyx Pharmaceuticals' Receivables - Other is $100,000, which was down 80.00% from $500,000 recorded in FY2023.
  • Over the past 5 years, Amylyx Pharmaceuticals' Receivables - Other peaked at $500,000 during FY2022, and registered a low of $100,000 during FY2024.
  • In the last 3 years, Amylyx Pharmaceuticals' Receivables - Other had a median value of $500,000 in 2023 and averaged $366,667.
  • Data for Amylyx Pharmaceuticals' Receivables - Other shows a maximum YoY crashed of 80.00% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Amylyx Pharmaceuticals' Receivables - Other stood at $500,000 in 2022, then remained steady at $500,000 in 2023, then plummeted by 80.00% to $100,000 in 2024.